tiprankstipranks
Exelixis (EXEL)
NASDAQ:EXEL
US Market
EXEL
Exelixis
RESEARCH TOOLSreports
Want to see EXEL full AI Analyst Report?

Exelixis (EXEL) Stock News & Sentiment

3,150 Followers
Exelixis and Merck Advance Key Phase 3 Kidney Cancer Trial, Setting Up a New Catalyst for EXEL
Premium
Company Announcements
Exelixis and Merck Advance Key Phase 3 Kidney Cancer Trial, Setting Up a New Catalyst for EXEL
9d ago
EXEL
Hold Rating on Exelixis Amid Emerging Belzutifan Competition and Uncertain Cabo Revenue Visibility
Premium
Ratings
Hold Rating on Exelixis Amid Emerging Belzutifan Competition and Uncertain Cabo Revenue Visibility
2M ago
EXEL
Exelixis: Welireg Competition Tempers RCC Upside but Embedded Cabozantinib Franchise Supports Hold Rating
Premium
Ratings
Exelixis: Welireg Competition Tempers RCC Upside but Embedded Cabozantinib Franchise Supports Hold Rating
2M ago
EXEL
Crocs, Linde, Zillow, Exelixis, Qorvo: Insider Cash-Outs
Premium
Weekend Updates
Crocs, Linde, Zillow, Exelixis, Qorvo: Insider Cash-Outs
2M ago
Z
LIN
Exelixis: Solid Financial Beat and Advancing Oncology Pipeline Drive Upgraded Earnings Outlook and $54 Price Target
Premium
Ratings
Exelixis: Solid Financial Beat and Advancing Oncology Pipeline Drive Upgraded Earnings Outlook and $54 Price Target
3M ago
EXEL
Exelixis Earnings Call: CABOMETYX Strength, ZANZA Catalyst
Premium
Company Announcements
Exelixis Earnings Call: CABOMETYX Strength, ZANZA Catalyst
3M ago
EXEL
Exelixis: Solid Q4 Execution and Advancing Pipeline Underpin Buy Rating and 2026 Earnings Power
Premium
Ratings
Exelixis: Solid Q4 Execution and Advancing Pipeline Underpin Buy Rating and 2026 Earnings Power
3M ago
EXEL
More EXEL News >

EXEL News on the Web

Exelixis price target raised to $45 from $44 at Barclays
TipRanks News
Neutral
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks News
Bullish
Wells Fargo Sticks to Its Hold Rating for Exelixis (EXEL)
TipRanks News
Neutral
Baseball has a 30-30 Club, Why Not Companies?
GuruFocus News
Neutral
Exelixis (EXEL) Gets a Hold from RBC Capital
TipRanks News
Bearish
Exelixis (EXEL) is a Top-Ranked Value Stock: Should You Buy?
Zacks
Bullish
Wells Fargo Sticks to Its Hold Rating for Exelixis (EXEL)
TipRanks News
Bearish
Here's Why Exelixis (EXEL) is a Strong Growth Stock
Zacks
Neutral

News Score - Last 7 Days

Neutral
EXEL
Sector Average
Media Buzz
This Week4 articles
Weekly Average2 articles
News Sentiment
This Week100%
Sector Average70%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is EXEL’s Media Buzz Sentiment?
4 articles about EXEL were published this week. In an average week, 2 articles are published.
    What is EXEL’s weekly average amount of articles?
    In an average week, 2 articles about EXEL are published.
      What is EXEL’s News Sentiment?
      100% of articles about EXEL were positive this week, compared to its sector average of 70%.
        Healthcare Stocks that are Trending in the News
        TVTXTravere Therapeutics
        HVOOpen Orphan Plc
        PBMPsyence Biomedical
        QDELQuidelOrtho
        Showing the stocks with the most bullish news sentiment over the past week